Mopidamol in non-small cell lung cancer: anti-oncogene or accident?
作者信息
Livingston R B
出版信息
J Natl Cancer Inst. 1988 Mar 16;80(2):77-8. doi: 10.1093/jnci/80.2.77.
PMID:2830406
Abstract
摘要
相似文献
1
Mopidamol in non-small cell lung cancer: anti-oncogene or accident?莫匹达莫在非小细胞肺癌中的作用：抗癌基因作用还是偶然现象？
J Natl Cancer Inst. 1988 Mar 16;80(2):77-8. doi: 10.1093/jnci/80.2.77.
2
Mopidamol.莫匹达醇
J Natl Cancer Inst. 1988 Jun 1;80(7):532-4. doi: 10.1093/jnci/80.7.532.
3
Effect of mopidamol on survival in carcinoma of the lung and colon: final report of Veterans Administration Cooperative Study No. 188.莫哌达醇对肺癌和结肠癌患者生存率的影响：退伍军人管理局第188号合作研究最终报告
J Natl Cancer Inst. 1988 Mar 16;80(2):90-7. doi: 10.1093/jnci/80.2.90.
4
[Adjuvant therapy of non-small cell bronchial cancer with mopidamol].[莫匹达莫对非小细胞支气管癌的辅助治疗]
Pneumologie. 1989 Jun;43(6):299-304.
5
Inhibitory action of flurbiprofen and mopidamole on tumor lung metastasis formation in mice.氟比洛芬和双嘧达莫对小鼠肿瘤肺转移形成的抑制作用。
Cancer Treat Rep. 1987 Nov;71(11):1089-90.
6
Antimetastatic effect of flurbiprofen and other platelet aggregation inhibitors.氟比洛芬及其他血小板聚集抑制剂的抗转移作用
Neoplasma. 1986;33(4):417-21.
7
Platelets and malignancy. Rationale and experimental design for the VA Cooperative Study of RA-233 in the treatment of cancer.血小板与恶性肿瘤。VA合作研究RA - 233治疗癌症的基本原理与实验设计。
Am J Clin Oncol. 1982 Dec;5(6):593-609. doi: 10.1097/00000421-198212000-00006.
8
[Molecular-targeted drug for non-small cell lung cancer].
Nihon Rinsho. 2012 Nov;70 Suppl 8:438-42.
9
Antimetastatic and antitumor effect of platelet aggregation inhibitors.
Prog Clin Biol Res. 1982;89:97-111.
10
Ceritinib (Zykadia) for non-small cell lung cancer.色瑞替尼（赞可达）用于治疗非小细胞肺癌。
Med Lett Drugs Ther. 2014 Jul 21;56(1447):62-3.
Zotero 插件